Search Results
Durata files NDA for infectious disease drug; KaloBios eyes $27.8M;
@FierceBiotech: Popular yesterday: In another stinging setback, Eli Lilly's ramucirumab fails PhIII breast cancer study. Article | Follow @FierceBiotech @JohnCFierce: ICYMI: Nektar Therapeutics... ...
Singulex grabs $55M in debt, equity for global in vitro diagnostics push
and raised $106 million. Molecular diagnostics company Veracyte also filed plans for a proposed IPO ...
Nektar Therapeutics shares crash on PhII pain drug trial flop
$70 million payday if the FDA accepts AstraZeneca's ($AZN) NDA for naloxegol, filed on Monday. ...
Sanofi betting on Lantus heir; EU OKs Boehringer cancer drug; Leo Burnett gets Pfizer biz;
Article Vaccines News > Merck KGaA lung cancer vaccine to re-enter Phase III. Item > GSK, Merck and Pfizer join JP Morgan vaccine investment fund. Report > European prices reapply old pressures to vaccine makers. Story > Pandemic leads researchers to universal flu vaccine 'blueprint.' More ...
Sarepta highlights continued stability in muscular dystrophy study; Adimab grabs third tech transfer deal; Transcept rejects Retrophin buyout bid;
to infrastructure issue in India. Article Vaccines News > Merck KGaA lung cancer vaccine to re-enter Phase III. Item > GSK, Merck and Pfizer join JP Morgan vaccine investment fund. Report > European prices reapply old pressures to vaccine makers. Story > Pandemic leads researchers to universal flu vaccine ...
Medtronic takes Insulet's settlement in insulin pump patent spat
of the settlement, the two will cross-license certain patents to one another and have agreed not to file anymore ...
Purdue building $59M plant in North Carolina
news tied to Durham lately. Merck ($MRK) this month said that the FDA had approved its Durham vaccine manufacturing plant to produce bulk varicella for its chickenpox and shingles vaccines.- here's ...
S&N rebrands wound care buy; Stent overuse linked to deaths;
warning points to infrastructure issue in India. Article Vaccines News > Merck KGaA lung cancer vaccine to re-enter Phase III. Item > GSK, Merck and Pfizer join JP Morgan vaccine investment fund. Report > European prices reapply old pressures to vaccine makers. Story > Pandemic leads researchers to universal ...
UPDATED: Foundation Medicine, Ophthotech go gangbusters in 2013 biotech IPO revival
but like a lot of biotechs, it is largely awash in red ink. Its SEC filing spells out that the company ...
Injectables plant in Mylan deal receives FDA warning; Vietnam lifts ban on pentavalent vaccine;
> The FDA has sent a warning letter to a sterile injectables vaccine plant Mylan ($MYL) is buying. News > Vietnam has lifted its ban on Crucell's pentavalent vaccine after an investigation proved its safety. Item > New York Magazine has taken a look at work to create a vaccine for cocaine ...
